Severe Lipodystrophy Following Prolonged Subcutaneous Administration of Antisense Oligonucleotides

JAMA Dermatol. 2019 Sep 1;155(9):1084-1086. doi: 10.1001/jamadermatol.2019.1404.
No abstract available